A clinical study to see the effects of two different drugs, in patients undergoing laser for angle closure glaucoma
Phase 4
Completed
- Conditions
- Health Condition 1: H408- Other glaucomaHealth Condition 2: null- Primary angle closure suspects undergoing laser peripheral iridotomy
- Registration Number
- CTRI/2017/12/010922
- Lead Sponsor
- Aravind eye hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 152
Inclusion Criteria
1. Best corrected visual acuity 6/9 or more
2. Primary angle closure suspects
Exclusion Criteria
1. Corneal pathology
2. Significant cataract (obscuring undilated fundus view)
3. Intra ocular pressure more than 21 mm of Hg
4. Peripheral anterior synechiae
5. Glaucomatous optic neuropathy
6. History of use of topical or systemic steroids one month prior to laser iridotomy
7. History of use of topical or systemic NSAIDS one month prior to laser iridotomy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare level of anterior chamber inflammation control between 0.1% Nepafenac and 1% Prednisolone acetate groups.Timepoint: 2 weeks and 4 weeks post laser
- Secondary Outcome Measures
Name Time Method To compare the changes in IOP between 0.1% Nepafenac and 1% Prednisolone acetate groups.Timepoint: 2 weeks and 4 weeks post laser